Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
19/01/2024 13:09
Jan 19 (Reuters) - Rain Oncology Inc RAIN.O :
* RAIN ONCOLOGY- PURSUANT TO PROPOSED DEAL WITH PATHOS AI,
15
DEMAND LETTERS HAVE BEEN SENT TO CO BY PURPORTED CO STOCKHOLDERS
* RAIN ONCOLOGY INC: DENIES ALL "ALLEGATIONS" IN DEMAND
LETTERS
SENT BY PURPORTED COMPANY STOCKHOLDERS
* RAIN ONCOLOGY INC - 15 DEMAND LETTERS SENT TO CO BY
PURPORTED
COMPANY STOCKHOLDERS RAISING "ALLEGED DISCLOSURE DEFICIENCIES IN
THE SCHEDULE 14D-9"
* RAIN ONCOLOGY INC: DETERMINED TO VOLUNTARILY SUPPLEMENT
SCHEDULE
14D-9 WITH SUPPLEMENTAL DISCLOSURE
Further company coverage: RAIN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rain Oncology
See all newsBrief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing
Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights
Brief: Rain Oncology Q3 Net Income USD -7.034 Million